News

Personalized Medicine Care Diagnostics Laboratory (PMCDx) is a mission-driven company that translates precision medicine approaches into routine clinical practice. It uses an individual’s genomic signature to provide a more precise and accurate therapy plan, like tailored drug therapy. In addition to simply reporting the genetic test results, PMCDx provides guidance to clinicians and patients about how to incorporate that genetic information in their personal therapy plan considering drug-drug interactions, lifestyle, diet, and smoking status.

The GW Medical Faculty Associates recently received a gift from Personalized Medicine Care Diagnostics (PMCDx), an advanced molecular diagnostic testing laboratory, in memory of Manny Velasquez, MD, Professor Emeritus of Medicine at GW SMHS and a long-time nephrologist at the GW MFA, who passed away in January 2021 just five days after his 82nd birthday.

Sherry Dadgar ’08 MS (bioinformatics) wants the future of medicine to empower patients. Dadgar, a clinical assistant professor of medicine at George Washington University, launched her company, Personalized Medicine Care Diagnostics (PMCDx), in 2020 with a goal of delivering advanced clinical genomic diagnostic testing to patients and their physicians.